The short answer
Testicular cancer has one of the highest survival rates of any cancer. SEER's modeled overall five-year relative survival is about 97%. Even distant (metastatic) testicular cancer, using American Cancer Society figures based on SEER data, has a 72% five-year relative survival, reflecting how well it responds to chemotherapy.
A survival statistic describes a large group diagnosed years ago — not a prediction for any one person.
SEER reports 94.6% five-year relative survival for testicular cancer overall, in people diagnosed 2016–2022.
Stage at diagnosis makes a large difference: localized disease is 99% versus 72% for distant (metastatic) disease.
Testicular cancer remains highly treatable even after it has spread, because it responds unusually well to chemotherapy.
Choose how you want to understand this
The full explanation.
Before you look at the numbers
Three things are true about the numbers below. Please read all three before any testicular cancer percentage.
First, a "5-year relative survival rate" for testicular cancer describes a large group of people. Those people were diagnosed with testicular cancer years ago. It is not a prediction about you. Everyone's testicular cancer, body, and treatment plan are different.
Second, this data lags behind today's care. SEER's overall figure covers people diagnosed between 2016 and 2022. The stage-specific figures come from the American Cancer Society and cover people diagnosed between 2015 and 2021. Testicular cancer treatment has been highly effective for decades. It also keeps being refined to cut long-term side effects. So testicular cancer treatment today may already work better than these numbers suggest.
Third, an all-stages testicular cancer number blends two very different groups. It mixes people whose testicular cancer was found early. It also counts people whose testicular cancer had already spread. For testicular cancer, the stage-specific numbers below beat one blended average. And "5-year" is just a measuring window, not a testicular cancer milestone. It is not a life expectancy for anyone with testicular cancer. It is not a deadline either.
The SEER numbers for testicular cancer
SEER reports five-year relative survival for testicular cancer of 94.6% for people diagnosed in 2016–2022, and its modeled trend line sits near 97%. Either way it is among the highest of any cancer type. The American Cancer Society uses the same SEER data, for people diagnosed between 2015 and 2021. It reports 99% survival for localized testicular cancer. Even for distant (metastatic) disease, it reports 72%.
Testicular cancer responds unusually well to chemotherapy, even after it has spread. That is why survival stays relatively high across every stage.
| Stage at diagnosis | 5-year relative survival |
|---|---|
| Localized — confined to the testicle | 99% |
| Regional — spread to nearby lymph nodes | 96% |
| Distant — spread to other parts of the body | 72% |
| Unknown/unstaged | 91% |
What "relative survival" actually means
Relative survival compares two groups. One group has testicular cancer. The other is the same age and sex, with no testicular cancer. Say the rate is 100%. That would mean the testicular cancer group was as likely to reach 5 years as the other. It is not the share of people who are free of testicular cancer. It is not the share of people who die from testicular cancer itself.
Testicular cancer is one of the most curable solid tumors, even at an advanced stage. The main reason is that it responds so well to cisplatin-based chemotherapy. It also often affects younger men. So care teams also plan for fertility preservation. That means protecting your ability to father children later. They work on limiting long-term side effects too.
What actually changes your outlook
A statistic describes a group. Your outlook depends on things specific to you.
- Stage — how far the testicular cancer has spread, as shown in the table above.
- Grade — how odd the testicular cancer cells look, and how fast they grow.
- Tumor type — seminoma versus non-seminoma germ cell tumors are treated somewhat differently.
- Tumor markers (AFP, hCG, LDH) — blood tests that help diagnose and track testicular cancer.
- How your testicular cancer responds — early scans and labs often say more than the first numbers.
- Your overall health — other health problems, age, and fitness shape testicular cancer treatment and recovery.
- Access to care — a quick testicular cancer diagnosis, specialist care, and finishing treatment.
Questions for your care team
- Which SEER stage describes my testicular cancer, and what is its five-year number?
- Which biomarkers or molecular tests matter in testicular cancer, and were they run on my sample?
- How do my age and overall health change these testicular cancer statistics for me?
- Are there newer testicular cancer treatments available now that this data doesn't reflect yet?
- Beyond the general testicular cancer statistics, what does my team expect in my case?
- Where can I find support for how it feels to hear these testicular cancer numbers?
- Is my testicular cancer a seminoma or non-seminoma, and what are my tumor marker levels?
If these numbers are hard to sit with
Testicular cancer numbers can leave you scared, numb, or overwhelmed. That is normal. It does not mean you are handling a testicular cancer diagnosis the wrong way. Many people take these testicular cancer numbers in slowly, or with someone in the room. Others skip the numbers until they feel ready. Cancer Anxiety and Uncertainty covers the fear these testicular cancer numbers can stir up. It is also worth telling your testicular cancer team how much detail you want, and when.
Sources
Words to know
Tap any term to see what it means.
Common questions
What does SEER's 94.6% five-year relative survival mean for testicular cancer?
It means that, on average, people diagnosed with testicular cancer between 2016 and 2022 were about 94.6% as likely to be alive 5 years later as people of the same age and sex without testicular cancer. It blends every stage together, from early to advanced.
Why is the stage-specific number so different from the overall number?
The overall number blends people found early, when testicular cancer is most treatable, with people found later. Stage makes a large difference — see the table above. Localized testicular cancer usually has a much higher five-year relative survival than distant (metastatic) disease.
Does this number predict what will happen to me?
No. This is a statistic about a large group of people, not a prediction about you. Your age, overall health, tumor biology, and how your testicular cancer responds to treatment all shape your individual outlook in ways a group statistic cannot capture.
Is this the most current data available?
The overall figure is SEER's most recent, and it covers people diagnosed between 2016 and 2022. The stage-by-stage figures come from the American Cancer Society, which has not moved them on yet, so they still cover 2015 to 2021. Treatments keep changing, so people diagnosed today may do better than either set of numbers suggests.
If testicular cancer is this treatable, why does stage still matter?
Even though testicular cancer responds unusually well to treatment at every stage, earlier-stage disease generally needs less intensive treatment; for example, surgery alone versus surgery plus multiple rounds of chemotherapy. Knowing your stage still helps predict how much treatment you're likely to need, even though the overall outlook is favorable at every stage.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-08-19Next planned review: 2027-08-03
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share